48,308 Shares in Lam Research Corporation $LRCX Purchased by Allstate Corp

Allstate Corp acquired a new position in Lam Research Corporation (NASDAQ:LRCXFree Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 48,308 shares of the semiconductor company’s stock, valued at approximately $3,512,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in LRCX. Vanguard Group Inc. lifted its stake in shares of Lam Research by 6.9% in the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after purchasing an additional 8,364,375 shares during the period. Ameriprise Financial Inc. raised its holdings in Lam Research by 950.5% in the fourth quarter. Ameriprise Financial Inc. now owns 34,543,915 shares of the semiconductor company’s stock worth $2,495,128,000 after purchasing an additional 31,255,726 shares in the last quarter. Invesco Ltd. lifted its position in Lam Research by 2.8% during the first quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company’s stock valued at $1,259,947,000 after buying an additional 472,636 shares during the period. Northern Trust Corp boosted its holdings in shares of Lam Research by 1,067.0% during the 4th quarter. Northern Trust Corp now owns 15,869,244 shares of the semiconductor company’s stock valued at $1,146,235,000 after buying an additional 14,509,407 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Lam Research by 6,383.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,574,691 shares of the semiconductor company’s stock worth $980,500,000 after buying an additional 13,365,317 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Price Performance

Shares of LRCX opened at $100.08 on Friday. The company has a market capitalization of $126.66 billion, a P/E ratio of 24.06, a price-to-earnings-growth ratio of 1.28 and a beta of 1.65. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $108.02. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. The firm has a 50 day moving average of $98.41 and a 200 day moving average of $84.59.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, beating the consensus estimate of $1.21 by $0.12. The business had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company’s revenue was up 33.6% compared to the same quarter last year. During the same period last year, the business posted $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on LRCX shares. Wells Fargo & Company set a $98.00 price target on shares of Lam Research and gave the company an “equal weight” rating in a research report on Thursday, July 31st. Oppenheimer raised their target price on shares of Lam Research from $110.00 to $120.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. Morgan Stanley lifted their target price on shares of Lam Research from $87.00 to $94.00 and gave the company an “equal weight” rating in a report on Thursday, July 31st. B. Riley restated a “buy” rating and issued a $115.00 price target (up previously from $95.00) on shares of Lam Research in a research note on Wednesday, June 18th. Finally, Barclays set a $83.00 price objective on Lam Research and gave the company an “equal weight” rating in a research report on Monday, July 28th. Twenty investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and a consensus price target of $107.30.

View Our Latest Report on LRCX

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Read More

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.